Please assess the completion status of the following clinical trial:

Trial Title: To Confirm Equivalent Bronchodilator Efficacy of the Test Product Compared to the Reference Product

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Main inclusion criteria:~* Written informed consent~* Asthma diagnosis for at least 6 months~* Prebronchodilator FEV1 45-90% of the predicted value~* Demonstration of reversible airway obstruction~* Stable asthma on the same regular treatment for at least 4 weeks before the study~* Non-smoker for at least 6 months before the study~Main exclusion criteria~* Respiratory infection within 4 weeks before the study~* Smoking history of more than 10 pack-years~* Other severe chronic respiratory disease than asthma~* Concurrent illness that would interfere with the interpretation of the study results or constitute a health risk for the patient if he/she takes part in the study~* Corrected QT interval \> 450 ms in males or \> 470 ms in females~* Abnormal serum potassium value or other clinically significant laboratory finding~* Systolic blood pressure over 180 mmHg and/or diastolic blood pressure over 100 mmHg~* Treatment with a long-acting β2-agonist, a xanthine-derivative, a β-blocker or with a corticosteroid (other than inhaled) within 4 weeks before the study~* Use of drugs that prolong QT-interval~* Women who are pregnant, breast-feeding or without reliable contraception~* Participation in another clinical drug study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Budesonide/formoterol Easyhaler 320/9 ug/inhalation 4 inh (Type: EXPERIMENTAL): Budesonide/formoterol Easyhaler 320/9 ug/inhalation 4 inh Placebo Symbicort Turbuhaler 320/9 ug/inhalation 4 inh
- Budesonide/formoterol Easyhaler 320/9 ug/inhalation 1 inh (Type: EXPERIMENTAL): Budesonide/formoterol Easyhaler 320/9 ug/inhalation 1 inh Placebo Symbicort Turbuhaler 320/9 ug/inhalation 1 inh
- Symbicort Turbuhaler 320/9 ug/inhalation 4 inh (Type: EXPERIMENTAL): Symbicort Turbuhaler 320/9 ug/inhalation 4 inh Placebo Budesonide/formoterol Easyhaler 320/9 ug/inhalation 4 inh
- Symbicort Turbuhaler 320/9 ug/inhalation 1 inh (Type: EXPERIMENTAL): Symbicort Turbuhaler 320/9 ug/inhalation 1 inh Placebo Budesonide/formoterol Easyhaler 320/9 ug/inhalation 1 inh

Based on this trial design, predict the completion outcome and termination type (if applicable).